10.07.2015 Views

who medicines strategy - libdoc.who.int - World Health Organization

who medicines strategy - libdoc.who.int - World Health Organization

who medicines strategy - libdoc.who.int - World Health Organization

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

WHO MEDICINES STRATEGY 2004-2007 | 24Figure 3:Ensuring access to essential <strong>medicines</strong> requires acoordinated set of actionsPRIORITIES FOR 2004-2007The central priority for 2004-2007 remains thatof expanding access to essential <strong>medicines</strong>,one of the health-related MDGs to which the<strong>int</strong>ernational community is committed. Toachieve this goal, WHO will emphasize access toall essential <strong>medicines</strong>, including those for HIV/AIDS, TB, malaria, and childhood illness.Ensuring access to essential <strong>medicines</strong> dependson success in putting in place the four key piecesof the access puzzle: rational selection, affordableprices, sustainable financing, and reliable healthsupply systems (Figure 3). Work in this areawill include analysis of effective drug supplystrategies, including supply services operated byfaith-based organizations.Within the overall objective of access, WHO willgive the greatest attention to scaling up access toARVs to meet the WHO target of ensuring that3 million people in developing countries haveaccess to treatment for HIV/AIDS by 2005.New and continued priorities in the area ofnational <strong>medicines</strong> policies include:> implementation of the WHO TraditionalMedicine Strategy> promotion and monitoring of access toessential <strong>medicines</strong> as a human right> greater attention to innovation to ensure thedevelopment of new <strong>medicines</strong> for neglecteddiseases and other priority needs> ensuring a public health-oriented approach tonational implementation of trade agreements> promoting a stronger ethical dimension in thepharmaceutical sector, including the use ofanti-corruption measures.Finally, during 2004-2007 increased attention willbe given to <strong>medicines</strong> safety through expandedsafety monitoring and continued strengthening ofquality assurance.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!